Byron Arana

4.8k total citations
81 papers, 3.5k citations indexed

About

Byron Arana is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Parasitology. According to data from OpenAlex, Byron Arana has authored 81 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Public Health, Environmental and Occupational Health, 36 papers in Epidemiology and 11 papers in Parasitology. Recurrent topics in Byron Arana's work include Research on Leishmaniasis Studies (48 papers), Trypanosoma species research and implications (33 papers) and Parasites and Host Interactions (10 papers). Byron Arana is often cited by papers focused on Research on Leishmaniasis Studies (48 papers), Trypanosoma species research and implications (33 papers) and Parasites and Host Interactions (10 papers). Byron Arana collaborates with scholars based in United States, Guatemala and United Kingdom. Byron Arana's co-authors include Anaité Díaz-Artiga, Thomas R. Navin, Kirk R. Smith, Nidia Rizzo, Nigel Bruce, Axel Kroeger, John P. McCracken, Alan Hubbard, J. D. Berman and Jorge Alvar and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Clinical Microbiology Reviews.

In The Last Decade

Byron Arana

76 papers receiving 3.4k citations

Peers

Countries citing papers authored by Byron Arana

Since Specialization

Citations

This map shows the geographic impact of Byron Arana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Byron Arana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Byron Arana more than expected).

Fields of papers citing papers by Byron Arana

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Byron Arana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Byron Arana. The network helps show where Byron Arana may publish in the future.

Co-authorship network of co-authors of Byron Arana

This figure shows the co-authorship network connecting the top 25 collaborators of Byron Arana. A scholar is included among the top collaborators of Byron Arana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Byron Arana. Byron Arana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Insights into the transmission cycle of cutaneous leishmaniasis from an endemic community in rural Guatemala 2025 ·Current Research in Parasitology and Vector-Borne Diseases ·(unknown), Aitor Casas-Sánchez, Byron Arana, Nidia Rizzo, (unknown), Norma Padilla, (unknown), (unknown), Álvaro Acosta-Serrano, (unknown)	0
2	Immunotherapeutic Strategies as Potential Treatment Options for Cutaneous Leishmaniasis 2024 ·Vaccines ·(unknown), (unknown), Charles E. Mowbray, Byron Arana	4
3	Involving patients in drug development for Neglected Tropical Diseases (NTDs): A qualitative study exploring and incorporating preferences of patients with cutaneous leishmaniasis into Target Product Profile development 2024 ·PLoS neglected tropical diseases ·María del Mar Castro, Astrid C. Erber, Byron Arana, Gláucia Cota, Claudia M. Denkinger, Nicole Harrison, (unknown), (unknown), Emma Plugge, Julia Walochnik, Piero Olliaro	2
4	A neglected among the neglected: a review of cutaneous leishmaniasis in Guatemala 2023 ·Transactions of the Royal Society of Tropical Medicine and Hygiene ·(unknown), Byron Arana, Nidia Rizzo, (unknown), Álvaro Acosta-Serrano, (unknown)	2
5	A phase II multicenter randomized study to evaluate the safety and efficacy of combining thermotherapy and a short course of miltefosine for the treatment of uncomplicated cutaneous leishmaniasis in the New World 2022 ·PLoS neglected tropical diseases ·Liliana López, (unknown), (unknown), Ana Pilar Ramos, Alejandro Llanos‐Cuentas, Juan Echevarría, Iván Darío Vélez, (unknown), (unknown), (unknown), (unknown), (unknown), Claudia Méndez, Byron Arana	10
6	Target Product Profile for a point-of-care diagnostic test for dermal leishmaniases 2019 ·Parasite Epidemiology and Control ·Israel Cruz, Audrey Albertini, (unknown), Byron Arana, Albert Picado, José A Ruiz-Postigo, Joseph Mathu Ndung’u	26
7	A phase II study to evaluate the safety and efficacy of topical 3% amphotericin B cream (Anfoleish) for the treatment of uncomplicated cutaneous leishmaniasis in Colombia 2018 ·PLoS neglected tropical diseases ·Liliana López, Iván Darío Vélez, (unknown), (unknown), Fabiana Alves, Sara M. Robledo, Byron Arana	46
8	Post-kala-azar dermal leishmaniasis in the Indian subcontinent: A threat to the South-East Asia Region Kala-azar Elimination Programme. 2017 ·PLoS neglected tropical diseases ·Eduard E. Zijlstra, Fabiana Alves, Suman Rijal, Byron Arana, Jorge Alvar	89
9	Transmission Dynamics of Visceral Leishmaniasis in the Indian Subcontinent – A Systematic Literature Review 2016 ·PLoS neglected tropical diseases ·Siddhivinayak Hirve, Marleen Boelaert, Greg Matlashewski, Dinesh Mondal, Byron Arana, Axel Kroeger, Piero Olliaro	57
10	Introducing Single Dose Liposomal Amphotericin B for the Treatment of Visceral Leishmaniasis in Rural Bangladesh: Feasibility and Acceptance to Patients and Health Staff 2014 ·Journal of Tropical Medicine ·(unknown), Mahbub Hassan, M. Mamun Huda, Debashis Ghosh, Md Shakhawat Hossain, Abdul Alim, Axel Kroeger, Byron Arana, Dinesh Mondal	10
11	Dengue vector management using insecticide treated materials and targeted interventions on productive breeding-sites in Guatemala 2012 ·BMC Public Health ·Nidia Rizzo, (unknown), (unknown), Byron Arana, Axel Kroeger, Pablo Manrique‐Saide, Max Petzold	45
12	Ambisome plus miltefosine for Indian patients with kala-azar 2010 ·Transactions of the Royal Society of Tropical Medicine and Hygiene ·Shyam Sundar, Prabhat Kumar Sinha, Deepak Verma, Nawin Kumar, (unknown), Krishna Pandey, Poonam Kumari, (unknown), Jaya Chakravarty, Neena Verma, Jonathan Berman, (unknown), Byron Arana	27
13	Evaluation of a pre-existing, 3-year household water treatment and handwashing intervention in rural Guatemala 2009 ·International Journal of Epidemiology ·Benjamin F. Arnold, Byron Arana, Daniel Mäusezahl, Alan Hubbard, John M. Colford	106
14	Eye discomfort, headache and back pain among Mayan Guatemalan women taking part in a randomised stove intervention trial 2006 ·Journal of Epidemiology & Community Health ·Esperanza Díaz, Tone Smith‐Sivertsen, Daniel Pope, Rolv T. Lie, Anaité Díaz-Artiga, John P. McCracken, Byron Arana, Kirk R. Smith, Nigel Bruce	112
15	Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala. 2001 ·American Journal of Tropical Medicine and Hygiene ·Byron Arana, Carmen Mendoza, Nidia Rizzo, Axel Kroeger	99
16	Evaluation of a standardized leishmanin skin test in Guatemala 1999 ·Transactions of the Royal Society of Tropical Medicine and Hygiene ·Byron Arana, (unknown), Nidia Rizzo, Carlos E. Mendoza‐Santiesteban, Axel Kroeger	6
17	Human infection with Trypanosoma cruzi induces parasite antigen-specific cytotoxic T lymphocyte responses. 1998 ·Journal of Clinical Investigation ·Benjamin Wizel, (unknown), Carmen de Mendoza, Byron Arana, John Sidney, Alessandro Sette, Rick L. Tarleton	65
18	Efficacy of a Short Course (10 Days) of High-Dose Meglumine Antimonate With or Without Interferon- in Treating Cutaneous Leishmaniasis in Guatemala 1994 ·Clinical Infectious Diseases ·Byron Arana, Thomas R. Navin, (unknown), J. D. Berman, F. Rosenkaimer	44
19	Placebo-Controlled Clinical Trial of Sodium Stibogluconate (Pentostam) versus Ketoconazole for Treating Cutaneous Leishmaniasis in Guatemala 1992 ·The Journal of Infectious Diseases ·Thomas R. Navin, Byron Arana, (unknown), J. D. Berman, (unknown)	242
20	Comparison of Active and Passive Case Detection of Cutaneous Leishmaniasis in Guatemala 1990 ·American Journal of Tropical Medicine and Hygiene ·Hannah Copeland, Byron Arana, Thomas R. Navin	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact